Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice post, we do know there's been no prep underway for expansion. The employee count is an obvious clue of direction. My opinion, a complete IPIX sale is pending results... Don't see much future if they miss... They are years away from other projects having much impact or starting a P3. Locust Walk and Alphasigma have both been disappointments
Your suggesting market makers are buying shares? They create a market for supply/demand... The public who buy/sell dictate the direction... The fascination here about market makers is unreal.
IPIX's website has all 21 slides in the PDF....
https://www.ipharminc.com/new-events-and-presentations/2021/7/21-american-society-of-virology-annual-meeting
https://static1.squarespace.com/static/5715352e20c647639137f992/t/60f98b02dee5a72cfce0c44e/1626966816579/GMU+ASV+2021+Brilacidin+talk+fv+7.21.21.pdf
We are excited about our upcoming data release, if successful we intend to pursue emergency use with the FDA or other venues... Enough of the development/studying crap... They had 16 months to study and test... Feast or famine time...
Why seeing continued studying and development being dangled in press releases is a concern... The focus should be on emergency use and possibly phase 3... Who cares about a 5 to 10 year development plan... The share price will go no place until the "pretend" CEO confirms an actual strategy...
Trial results will determine B's future with viruses. You honestly believe IPIX has the resources to play R&D for X more years?
Volume 291K as of 10:40 EST... LOL Now back to Summer vacations after GMU does the presenting.
If Leo mentioned one goal being emergency use the stock would be .40 plus... He has every the right to mention EU...
Yawn, on to the next presentation... All that matters is good data validating the presentations... If data fails the B for virus projects will be suspended...
Leo seems afraid to mention phase 3 or emergency use? Studies and development is fine for Pfizer but not a 2 person biotech on life-support... Like I've said all year, does Leo have a plan to make B available ASAP? The study/development chatter is not what shareholders want to read.
Bingo, hit the nail on the head... The after planning is just as critical as the data... OM/UP and Assssi all passed their endpoints... All 3 sit shelved... No difference for B for C if there's no interest or funding... OM was thought to be one of a few treatments? Abssssi comparisons to Cubist/Merck...
IPIX Rally Monkey for Monkeypox... Leo's next PR he can reference a new project...
https://www.aol.com/news/more-200-people-may-exposed-170711071.html
Everything rides on data... Presentations ahead of results are tainted since trial outcome will determine B for C's future... Will be interesting to see if data is released ahead of the military conference? If it is not, speculation will grow that data missed with Leo stalling for the truth.
Correct, any stock trading 20 pennies is considered dead to the real investment world. The only reason IPIX is still alive was the CV19 hype... If data misses doubt any of their other projects can save them. Why it was important to have other activity ahead of results... Also, many here are dissing the need for employee hires which is a leading indicator for growth. Guess Leo will start the next Regeneron hiring if data succeeds? As of now, all signs point to prepping for failure. Another clue is the developmental continued reference in press releases and email alerts... B needs to be put in use ASAP not a R&D project for a dying biotech.
2035, My cold is bad today, pass me the Brilacidin tablet.... LOL
If they (IPIX) want to be taken serious as a public traded company it would make sense to not have the CEO with no checks and balances. Leo is the entire company (CEO/CFO/Chairman/HR/COO) so he should take them private? Oh that's right, he couldn't raise funds without dumping shares... He'd have to find a REAL lender/partner not penny flippers.
Or symbol IPIX posted on the presentation slide... One look from potential investors would scare anyone away... Even further, finding out they have 2 employees and no central office... Leo's poolside is more like it... Expansion plans for becoming the next Regeneron are down to Leo/Jane...
zandant Member Level Wednesday, 07/21/21 12:22:49 PM
Re: Hugon post# 366141 0
Post #
366145
of 366150
Be thankful that Leo is not presenting. This would open at .0001 tomorrow following his appearance.
Nothing ever changes in IPIX world. 2 day rally from the graveyard for a meaningless presentation and media hyped Delta Variant.... Back to bed IPIX until the next presentation..
You surprised? Probably was your trade...
Yes, just like Prurisol was a lock... Doubt many will jump aboard until after data release... What's the hurry? They've had successful phase 2 trials before and the stock dropped. If this was phase 3 different story...Even with good results will master Leo have a partner or buyer lined up? Will they need an expensive phase 3 in 2022? Some are assuming good data will cure all ills...
Incorrect, the volume is actually the same as yesterday's pace... doubt we'll see a greater total...
Nope, it rallied (2 days) because the stock was dead so long the recent uptick in the Virus cases in-the-news brought back some interest... Throw in this weeks presentation a few shorts covered with the MMs playing fake rally... This stock is DEAD until data release...
This will close down 10 percent or more which was expected... Kips Bay can sell at maximum profit...
The stock rose 25 percent on no specific news... A presentation is not worthy news unless those who attend verify there will be interest in IPIX stock which would be impossible to ever know... Judgement Day mid to late August...
The Rally Monkey running out-of-gas... two to three days is the norm....
Yes, which has meant in the past a quick run-up followed by profit taking... If there was legit news this morning then it's a different story...
Leo was not specific...
has been accepted for an Oral Presentation at the American Society of Virology’s 40th Annual Meeting (ASV 2021), taking place July 19-23, 2021.
Also, here are the sponsors of the event. IPIX could have applied... Need the money for Leo's retirement...
https://asv.org/asv2021/sponsors-donors/
MM activity not a trade... Don't pay attention to pre-market except the Bid/Ask around 09:29... IPIX does not have pre-market trading, it's market makers playing a game to draw buy orders in...
Schedule for this week... Browsing through the event website see no mention of GMU/B... The highlighted events are on this page... It will be like the other presentations 5 minutes, last hour... Poster sessions are Tue/Thu
6PM to 8PM EST.
https://asv.org/asv2021/scientific-program/#schedule-at-a-glance
Volume is terrible, most CV19 stocks have rallied the past few days, 600K traded is 125K dollar amount... Lets see a million plow into this...
.24, Leo did a somersault into his pool... Guess he'll have to PR this weeks presentation then back on vacation. nice job.....
If there's one positive low volume with 400 million outstanding indicates most are holding to data release... The recent COV19 cases might spark some interest. Moderna up big again today...
The drop from .40's down to .20 was light volume... The right news this will rebound fast. Hasn't been much to trigger off a sustained rally. 2 presentations and data results in mid August is the entire Summer so far. Need a 10 million volume day...
MM's let it run up a bit, now the sell orders increasing at .22...
Someone bought market, .232 for a short time
Nobody is denying the need for therapeutics the main question is B ready for prime-time or a developmental project? Data good or bad it will be the after statement which will the key... Emergency use, partner, grant, P3 and if data is bad what next? Developing B for future virus's will not move the needle...
Don't forget the common cold... Leo is always dangling out carrots for the next big thing to be developed... Never anything of substance in current time. He's already pushing the agenda with zero mention of emergency use or phase 3... They have all-the-time and staff/money to develop B/K... Nobody buys the BS except a few backers of his. Now the Alphasigma trial is starting when? LOL
All boils down to whether B is more effective than current treatments with possibly needing an expensive phase 3. Prime example was Absssi, even though many believe the trial was a success because they met their endpoints it never advanced due to revenue potential versus phase 3 expenses... Why Leo continues the development chatter in press releases and shareholder alerts... Nobody gives a damn about developing B for 2035... All the hype should be directed at emergency use and finding a partner for a quick as possible phase 3... The PPS shares the sentiment...
You compared the out shares not increasing to Kips not selling their shares. Again, shares from a filing have already been totaled into the outstanding figure. You can’t assume Kips has not been selling. They never have to file again if they stay below 5 percent.
Kips had 20 million from their last filing are you sure they sold them all? The 20 million when sold adds nothing to the out totals.